Stock MBVXQ MABVAX THERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News MabVax Therapeutics Holdings, Inc.

Equities

MBVXQ

US55414P7024

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for MabVax Therapeutics Holdings, Inc. +10.05% +182.21%
2020 MabVax Therapeutics Holdings, Inc. Went Out of Business CI
2020 Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MabVax Therapeutics Holdings, Inc. Went Out of Business
CI
Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc.
CI
Second Amended Liquidation Plan and Disclosure Statement Conditionally Approved for MabVax Therapeutics Holdings, Inc.
CI
Second Amended Combined Joint Liquidation Plan and Disclosure Statement Filed by MabVax Therapeutics Holdings, Inc.
CI
First Amended Combined Joint Liquidation Plan Filed by MabVax Therapeutics Holdings, Inc.
CI
Joint Liquidation Plan and Disclosure Statement Filed by MabVax Therapeutics Holdings, Inc.
CI
Second Motion for Exclusivity Period Extension Approved For MabVax Therapeutics Holdings, Inc.
CI
Motion for Exclusivity Period Extension Approved For MabVax Therapeutics Holdings, Inc.
CI
First Motion for Exclusivity Period Extension Filed by MabVax Therapeutics Holdings, Inc.
CI
Motion for Asset Sale Approved for MabVax Therapeutics Holdings, Inc.
CI
Bankruptcy Judge Changed for MabVax Therapeutics Holdings, Inc.
CI
BioNTech Research and Development, Inc. completed the acquisition of substantially all assets from MabVax Therapeutics Holdings, Inc..
CI
Motion for Asset Sale Approved for MabVax Therapeutics Holdings, Inc.
CI
Notice of Successful Bidder and Back-Up Bidder Filed by MabVax Therapeutics Holdings, Inc.
CI
Oncotelic Inc. cancelled the acquisition of MabVax Therapeutics Holdings, Inc. in a reverse merger transaction.
CI
Bidding Procedure Approved for MabVax Therapeutics Holdings, Inc.
CI
Final DIP Financing Approved for MabVax Therapeutics Holdings, Inc.
CI
Interim DIP Financing Approved for MabVax Therapeutics Holdings, Inc.
CI
Motion for Joint Administration Approved for MabVax Therapeutics Holdings, Inc.
CI
MabVax Therapeutics Holdings, Inc. Filed for Bankruptcy
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MBVXQ Stock
  4. News MabVax Therapeutics Holdings, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW